CNTNAP2 and channelopathy: We did not, however, find evidence of a significant inflammatory response within the peripheral or CNS in mice treated with CASPR2-Abs, and we hypothesized that CASPR2-Abs altered sensory function through the novel mechanism of an acquired channelopathy.